News

Scientists at Nagoya University in Japan studied what happens when macrophages—a type of immune cell—encounter dying cancer ...
A new AI tool, AAnet, has discovered five distinct cell types within tumors, offering a deeper look into cancer's inner ...
Brain Tumours, particularly malignant types such as glioblastoma multiforme (GBM), continue to pose a significant clinical ...
The collaborative research initiative will be focused on advancing approaches to enhance the therapeutic efficacy of ...
A multinational team of researchers, co-led by the Garvan Institute of Medical Research, has developed and tested a new AI ...
For roughly 400 years, microscopes have allowed us to observe increasingly smaller details. Today's most advanced instruments ...
Per a report by Precedence Research, the global cancer therapeutics market is expected to be worth around $393.61 billion by ...
A T cell killing a cancer cell. [Andrew Frisch and Donna Stolz, University of Pittsburgh Center for Biologic Imaging] Researchers at the University of Pittsburgh have developed a new way to grow T ...
Nevertheless, Anixa hopes to develop the first approved CAR T-cell therapy for a solid tumor indication. The company has identified a protein called the follicle-stimulating hormone receptor (FSHR ...